Zdrowie i gospodarka · 28/02/2003

FDA Reclassifies Automated Blood Cell Separator Device from Class III to Class II

The FDA is reclassifying the automated blood cell separator device, which is used to collect blood and blood components, from a Class III device to a Class II device with special controls, requiring annual reports on adverse reactions for a minimum of 3 years.